The first intradiscal allograft to succeed in a rigorous, sham-controlled trial for chronic lumbar discogenic pain, a leading driver of the world’s #1 cause of disability Rey Pascual, Vivex’s Co-President, added, “The strength of a rigorous sham-controlled trial marks a defining…
The team profiled more than 600,000 cells from across the fish to build the whole-body single-cell transcriptome atlas of which genes are active in which cell. A cell’s transcriptome is the full set of RNA molecules it has made from its…
The platform takes submitted sequences through CHO expression and characterization, generating expression and assay data within the same workflow. Depending on the selected package, antibodies are screened directly from supernatant or purified before further characterization. Binding measurements include BLI- or…
Panchase Protected Forest, in the hills above Nepal’s second city of Pokhara, is known among botanists as an orchid haven. Hundreds of species grow there, many of them found nowhere else in Nepal. I have been working in Panchase for…
New sites in the UK, France, Sweden, Germany, Italy and Spain will add to the global footprint of the pivotal SIGMA study Study site locations will be listed on ClinicalTrials.gov and updated as finalized. In August 2026, the FDA granted…
This retrospective study evaluated the impact of a pre-emptive rituximab (RTX) strategy for EpsteinâBarr virus (EBV) reactivation on immune recovery and outcomes of 219 high-risk recipients undergoing allogeneic stem cell transplantation (allo-SCT)... Thank you for visiting nature.com. You are…
In this Teach Me in 10, Dr. Uirá Souto Melo, molecular geneticist and CEO and co-founder of Lucid Genomics, explores the diagnostic potential of methylation analysis. Why Methylation Matters Now: Bridging Research and Diagnosis DNA sequence alone doesn’t tell the whole…
This eBook brings together perspectives from across the AAV development and manufacturing continuum. It explores how early commercial planning can help avoid costly delays, how standardized platform approaches and off-the-shelf plasmids can streamline development, and how next-generation innovations are helping…
In this whitepaper, Sartorius discusses the need to replace animal testing with advanced in vitro human cell models for pharmaceutical, chemical, and cosmetic development as, with only 5-10% of compounds entering clinical trials ultimately gaining approval, animal studies often fail to…
By Kevin Davies, PhD HAMBURG—The historic German port city of Hamburg is playing host to the European Society of Gene & Cell Therapy (ESGCT) conference this week. The statistics remain sobering: More than 40 million people live with HIV, but more…
The latest from biology's own science and trade publications, by subject: GEN, The Scientist, BioSpace, Endpoints, Nature, Mongabay, Seed World and more.
An article joins this feed when it matches these terms. Each one is also a search of its own.